Preliminary results from a trial conducted by the US National Institutes of Health showed that Remdesivir cut hospital stays by 31% compared to a placebo.
from Top Business News- News18.com
Read The Rest:timesnownews...
from Top Business News- News18.com
Read The Rest:timesnownews...
Gilead to End Coronavirus Drug Trials, Adding to Access Worry: Researchers
Reviewed by Team Exprssnews
on
May 15, 2020
Rating:
No comments: